TrialBMC cancer2022

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.

Yingjie Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.